Fundraising FoxWELL Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
ChromaDex supplies phytochemical reference standards and botanical reference materials used for research, method development, quality control, and regulatory compliance in the natural products industry.
BiotechHealthtechNew MaterialsIrvine, US
Frank Jaksch(President and CEO)inFrank L. Jaksch, Jr.(Chief Scientific Officer)Troy Rhonemus(COO)inThomas C. Varvaro(Chief Financial Officer, Treasurer and Secretary)inJeffrey Himmel(Chief Executive Officer)
BoardHugh Dunkerley(Director)
Board seatHamed Shahbazi· per SEC Form D · $3.1M raise · filed Oct 2022
Co-investorsHorizons Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.